Instituto de Alta Investigación, Universidad de Tarapacá, 1520, Antofagasta, Arica, Chile.
Universidad Católica del Norte, Avda. Angamos, 0610, Antofagasta, Chile.
Health Qual Life Outcomes. 2019 Nov 27;17(1):175. doi: 10.1186/s12955-019-1238-2.
To date, no data have been available concerning the psychometric characteristics of the Internalized Stigma of Mental Illness scale (ISMI-29) in Latin American countries. The aim of this study was to validate a Latin American version of the ISMI in people with schizophrenia.
The study included 253 stabilized outpatients with schizophrenia from 3 Mental Health Services in three Latin American countries: Bolivia (N = 83), Chile (N = 85) and Peru (N = 85). We analyzed the psychometric properties using item response and classical test theories. An item reduction was then performed to improve the psychometric properties of the ISMI-29. The final version of the ISMI was tested for construct validity, reliability, external validity and differential item functioning (DIF).
The five-factor structure of the ISMI-29 was not confirmed using confirmatory factor analysis (RMSEA = 0.12, CFI = 0.77, and WRMR = 2.20). Seventeen items were discarded to obtain a satisfactory psychometric version. The ISMI-12 evaluates 3 dimensions: social stigma (4 items), stigma experience (4), and self-stigma (3). The factor structure accounted for 68% of the total variance. Internal consistency was satisfactory. The scalability was satisfactory, with INFIT statistics within an acceptable range. In addition, the results confirmed the absence of DIF and supported the invariance of the item calibrations between countries.
The ISMI-29 is not valid in our sample and should not be used in Latin American countries. The ISMI-12 is the first internalized stigma questionnaire with satisfactory psychometric properties available in Latin American countries. Its brevity could facilitate its dissemination and use in clinical settings.
迄今为止,尚无有关拉丁美洲国家内心精神疾病耻辱感量表(ISMI-29)心理测量特性的数据。本研究的目的是验证拉丁美洲版 ISMI 在精神分裂症患者中的适用性。
该研究纳入了来自拉丁美洲 3 个国家(玻利维亚、智利和秘鲁)的 3 个心理健康服务机构的 253 名稳定的精神分裂症门诊患者。我们使用项目反应和经典测试理论分析了心理测量特性。然后进行项目删减,以改善 ISMI-29 的心理测量特性。最后对 ISMI-29 的结构效度、信度、外部效度和项目区分度(DIF)进行检验。
使用验证性因子分析(RMSEA=0.12、CFI=0.77 和 WRMR=2.20)未确认 ISMI-29 的五因素结构。为了获得满意的心理测量版本,我们删除了 17 个项目。ISMI-12 评估了 3 个维度:社会耻辱感(4 个项目)、耻辱感体验(4 个项目)和自我耻辱感(3 个项目)。因子结构解释了总方差的 68%。内部一致性令人满意。可扩展性令人满意,INFIT 统计值在可接受范围内。此外,结果证实不存在 DIF,并支持项目校准在国家间的不变性。
在我们的样本中,ISMI-29 无效,不应在拉丁美洲国家使用。ISMI-12 是拉丁美洲国家第一个具有满意心理测量特性的内化耻辱感问卷。其简短性可能有助于在临床环境中推广和使用。